Patent Grant
8192974
The present invention relates to a glucanase, and more particularly to a 1,3-1,4-β-
1,3-1,4-β-
There are two approaches to obtain a highly thermostable enzyme. The first is to directly clone the enzyme-coding genes from hyperthermophiles and to express the proteins in industrial strains. For instance, Thermotoga maritima cellulase 12A (TmCell2A) that belongs to the GH12 family of glycoside hydrolases shows the strongest activity at 95° C. and has a pH optimum of 5. These characteristics make the enzyme highly valuable in various utilizations, since industrial processes such as plant waste treatments usually involve high temperature and low pH. Nevertheless, the hyperthermophile-derived enzymes usually exhibit low activities in physiological conditions which are between 20 and 37° C., and thus severely limit their applications in aquatic and nonruminal animals. These hyperthermophilic enzymes still need to be modified to meet the requirement for different industrial usages. The second approach to obtain a thermostable enzyme is to directly modify a less thermostable enzyme by genetic manipulations.
Fibrobacter succinogenes 1,3-1,4-β-
Therefore, the present invention directly mutated the TF-glucanase gene in attempt to improve the enzyme activity and thermostability.
An object of the present invention is to modify a glucanase by means of site-directed mutagenesis to efficiently increase the enzyme activity and thermostability, reduce the production costs and enhance the industrial value.
According to an aspect of the present invention, there is provided a glucanase comprising modified amino acid sequence of SEQ ID NO: 2, wherein valine at position 18 is substituted with tyrosine and tryptophan at position 203 is substituted with tyrosine.
In an embodiment, a gene encoding the amino acid sequence of SEQ ID NO: 2 is a C-terminal truncated Fsβ-glucanase gene isolated from Fibrobacter succinogenes. The glucanase is a 1,3-1,4-β-
In an embodiment, the cellulase comprises an amino acid sequence of SEQ ID NO: 8.
According to another aspect of the present invention, there is provided a glucanase comprising modified amino acid sequence of SEQ ID NO: 2, wherein tryptophan at position 203 is substituted with tyrosine.
In an embodiment, a gene encoding the amino acid sequence of SEQ ID NO: 2 is a C-terminal truncated Fsβ-glucanase gene isolated from Fibrobacter succinogenes. The glucanase is a 1,3-1,4-β-
In an embodiment, the cellulase comprises an amino acid sequence of SEQ ID NO: 6.
According to an additional aspect of the present invention, there is provided a glucanase comprising modified amino acid sequence of SEQ ID NO: 2, wherein valine at position 18 is substituted with tyrosine.
In an embodiment, a gene encoding the amino acid sequence of SEQ ID NO: 2 is a C-terminal truncated Fsβ-glucanase gene isolated from Fibrobacter succinogenes. The glucanase is a 1,3-1,4-β-
In an embodiment, the cellulase comprises an amino acid sequence of SEQ ID NO: 4.
The above objects and advantages of the present invention will become more readily apparent to those ordinarily skilled in the art after reviewing the following detailed description and accompanying drawings, in which:
The present invention will now be described more specifically with reference to the following embodiments. It is to be noted that the following descriptions of preferred embodiments of this invention are presented herein for purpose of illustration and description only; it is not intended to be exhaustive or to be limited to the precise form disclosed.
In the present invention, a gene of Fsβ-glucanase, which encodes a protein of 1,3-1,4-β-
In order to increase the specific activity and thermostability of TF-glucanase, the site-directed mutagenesis was performed to obtain the mutants including V18Y, W203Y and V18Y/W203Y, wherein V18Y means valine at position 18 was mutated into tyrosine, W203Y means tryptophan at position 203 was mutated into tyrosine, and V18Y/W203Y is a double mutant in which valine at position 18 was mutated into tyrosine and tryptophan at position 203 was mutated into tyrosine. These mutants were prepared by using QuickChange site-directed mutagenesis kit (Agilent) with TF-glucanase-pET32Xa/LIC gene as the template, and the mutagenic primer sequences for these mutants were listed in
The recombinant plasmids of wild type and mutant TF-glucanases were transformed into E. coli BL21 (DE3) competent cell, respectively, and the transformed strains were screened by LB plate with 100 μg/ml Ampicillin. The transformed strains were inoculated and cultured into 5 ml LB medium and then amplified into 200 ml LB medium. Finally, the culture was grown into 6 L LB medium and incubated at 37° C. until OD600 reached 0.6-0.8. The protein expression was induced by adding 1 mM IPTG for 3 hours. After that, the cells were collected by centrifugation at 6000 rpm for 10 min. The cells were lysed in lysis buffer by sonicator and then centrifuged at 16000 rpm for 30 min to collect supernatants for purification. For obtaining highly purified protein, the TF-glucanase protein was purified by FPLC system using Ni2+ column and DEAE column. Finally, the TF-glucanase protein, which had above 95% purity, was concentrated up to 5 mg/ml in protein buffer (25 mM Tris and 150 mM NaCl, pH 7.5) and then was stored at −80° C.
The enzyme activity and thermostability of wild type and mutant TF-glucanases were further tested with the following process. 1 ml of enzyme solution (dissolved in 0.1 M sodium acetate, pH 5.0) was incubated with 1 ml substrate solution (1% β-glucan (w/v)) at 50° C. for 10 min. The reaction was stopped by adding 3 ml of DNS-reagent and the solution was boiled in water for 5 min to remove debris enzyme activity. After cooling in cold water bath for 5 min, the 540 nm absorbance of reaction solution was measured. The standard curve of enzyme activity was determined by 0-0.25 mg/ml glucose standard solution. One unit of β-glucanase activity was defined as the amount of enzyme required to liberate 1 μmol reducing sugar from β-glucan per minute per mg total soluble proteins under the assay conditions. As for the thermostability test, these TF-glucanases were pre-treated at several temperature points from 50° C. to 62° C., such as 50° C., 53° C., 55° C., 57° C., 59° C. and 62° C., for 2 min and then incubated in cold water bath for 5 min. The enzyme activities were obtained using the glucanase activity assay mentioned above.
From the above, the enzyme thermostability of TF-glucanase was improved when Val18 was mutated to tyrosine and the enzyme activity of TF-glucanase was improved when Trp203 was mutated to tyrosine. When both Val18 and Trp203 were mutated to tyrosine, the double mutant protein showed increased thermostability and enzyme activity as well, which also meant the two modification features resulted from V18Y and W203Y would not affect each other and were complementary to each other. Therefore, the V18Y/W203Y mutant is of much value to reduce the production cost and enhance the industrial application.
To test if the modified TF-glucanase protein can be expressed well in industrial expression system, Pichia pastoris expression system was used. The wild type TF-glucanase gene and the V18Y, W203Y and V18Y/W203Y mutant genes were cloned into pPICZαA vector by EcoRI and NotI. Each plasmid DNA was further linearized by PmeI and transformed into Pichia via electroporation. The transformed cells were then selected on YPD plate with 100 μg/ml zeocin at 30° C. for two days. The picked colonies were inoculated into 5 ml YPD medium at 30° C. overnight and further amplified into 50 ml BMGY medium at 30° C. overnight. After that, the cultured medium was changed to 20 ml BMMY with 0.5% methanol to induce the target protein expression. The samples were collected at different time points for every 24 hours and at that time 0.5% methanol was added, too. The samples were then centrifuged to collect supernatants and the glucanase activities were detected using the procedure mentioned above.
To test if the TF-glucanase can be mass produced by industrial scale of fermentation, the transformed cells were inoculated into 5 ml YPD medium at 30° C. overnight. Then, the culture was amplified into 2 L YPD medium and further transferred to 19 L fermentation medium (FBSM) in a 50 L fermentor. The manipulation of Pichia fermentation was generally followed with the guideline from Invitrogen. During fermentation process, temperature was maintained at 30° C. and pH was fixed to 5.0 by adding ammonium hydroxide. Dissolved oxygen was maintained above 40% by air flow rate and agitation rate. After batch phase, the carbon source was added by feeding 50% glycerol. Methanol was added to induce the protein expression. The protein expression yield and glucanase activity were monitored for every 12 hours. Consequently, the glucanase activity of the V18Y/W203Y mutant was significantly higher (up to 2-fold) than that of the wild type enzyme.
To further understand how the V18Y/W203Y mutant can improve the thermostability and enzyme activity, the structure of the V18Y/W203Y mutant protein was sloved by X-ray crystallography. First, the protein crystal was obtained by using sitting drop vapor diffusion method at room temperature. The crystal was first seen from crystal screen kits and the better crystal was obtained by a condition that contained 0.1 M Tris-HCl, pH 7.5, 0.3 M Calcium acetate, and 29% PEGSKMME. Then the crystal was soaked with mother liquor with 10 mM cellotetraose for 1 hour, and the diffraction data from the crystal were collected. After that, the crystal structure was determined by molecular replacement method using the crystallographic software of CNS program. Accordingly, the structure of the V18Y/W203Y mutant protein in complex with cellobiose (CLB) was sloved, as shown in
In conclusion, the present invention designed some mutations to improve the TF-glucanase thermostability and specific activity by site-directed mutagenesis based on previous solved X-ray TF-glucanase complex structures. For the V18Y and V18Y/W203Y mutants, 2° C. increment of temperature tolerance (Tm, changed from 57 to 59° C.) was observed; that is to say, the thermostability of TF-glucanase was improved when Val18 was mutated to tyrosine. As for the W203Y and V18Y/W203Y mutants, at least 1.6-fold increase in enzyme activity compared to the wild type enzyme was observed; that is to say, the enzyme activity of TF-glucanase was improved when Trp203 was mutated to tyrosine. Except the E. coli expression system, the V18Y/W203Y mutant also had better glucanase activity in the industrial used yeast strain, Pichia pastoris, by using flask and 50 L fermentor test. Therefore, the V18Y/W203Y mutant is of much value to reduce the production costs and enhance the industrial application, especially in food industry and feed industry.
While the invention has been described in terms of what is presently considered to be the most practical and preferred embodiments, it is to be understood that the invention needs not be limited to the disclosed embodiment. On the contrary, it is intended to cover various modifications and similar arrangements included within the spirit and scope of the appended claims which are to be accorded with the broadest interpretation so as to encompass all such modifications and similar structures.
| Number | Date | Country | Kind |
|---|---|---|---|
| 100107992 | Mar 2011 | TW | national |
| Number | Name | Date | Kind |
|---|---|---|---|
| 7527958 | Shyur et al. | May 2009 | B2 |
